Covid-19 Impact on Animal Pharmaceutical Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Animal Pharmaceutical Industry

1.7 COVID-19 Impact: Animal Pharmaceutical Market Trends

2 Global Animal Pharmaceutical Quarterly Market Size Analysis

2.1 Animal Pharmaceutical Business Impact Assessment - COVID-19

2.1.1 Global Animal Pharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Animal Pharmaceutical Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Animal Pharmaceutical Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Animal Pharmaceutical Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Animal Pharmaceutical Factory Price by Manufacturers

3.3 Location of Key Manufacturers Animal Pharmaceutical Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Animal Pharmaceutical Market

3.5 Key Manufacturers Animal Pharmaceutical Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Animal Pharmaceutical Segments, By Type

4.1 Introduction

1.4.1 Vaccine

1.4.2 Veterinary Drugs

1.4.3 Other

4.2 By Type, Global Animal Pharmaceutical Market Size, 2019-2021

4.2.1 By Type, Global Animal Pharmaceutical Market Size by Type, 2020-2021

4.2.2 By Type, Global Animal Pharmaceutical Price, 2020-2021

5 Impact of Covid-19 on Animal Pharmaceutical Segments, By Application

5.1 Overview

5.5.1 Companion Animal

5.5.2 Poultry

5.5.3 Other

5.2 By Application, Global Animal Pharmaceutical Market Size, 2019-2021

5.2.1 By Application, Global Animal Pharmaceutical Market Size by Application, 2019-2021

5.2.2 By Application, Global Animal Pharmaceutical Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Zoetis

7.1.1 Zoetis Business Overview

7.1.2 Zoetis Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.1.3 Zoetis Animal Pharmaceutical Product Introduction

7.1.4 Zoetis Response to COVID-19 and Related Developments

7.2 Merck

7.2.1 Merck Business Overview

7.2.2 Merck Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.2.3 Merck Animal Pharmaceutical Product Introduction

7.2.4 Merck Response to COVID-19 and Related Developments

7.3 Merial

7.3.1 Merial Business Overview

7.3.2 Merial Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.3.3 Merial Animal Pharmaceutical Product Introduction

7.3.4 Merial Response to COVID-19 and Related Developments

7.4 Elanco

7.4.1 Elanco Business Overview

7.4.2 Elanco Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.4.3 Elanco Animal Pharmaceutical Product Introduction

7.4.4 Elanco Response to COVID-19 and Related Developments

7.5 Bayer Animal Health

7.5.1 Bayer Animal Health Business Overview

7.5.2 Bayer Animal Health Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.5.3 Bayer Animal Health Animal Pharmaceutical Product Introduction

7.5.4 Bayer Animal Health Response to COVID-19 and Related Developments

7.6 Boehringer Ingelheim Vetmedica

7.6.1 Boehringer Ingelheim Vetmedica Business Overview

7.6.2 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.6.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Introduction

7.6.4 Boehringer Ingelheim Vetmedica Response to COVID-19 and Related Developments

7.7 Virbac

7.7.1 Virbac Business Overview

7.7.2 Virbac Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.7.3 Virbac Animal Pharmaceutical Product Introduction

7.7.4 Virbac Response to COVID-19 and Related Developments

7.8 Ceva Sante Animale

7.8.1 Ceva Sante Animale Business Overview

7.8.2 Ceva Sante Animale Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.8.3 Ceva Sante Animale Animal Pharmaceutical Product Introduction

7.8.4 Ceva Sante Animale Response to COVID-19 and Related Developments

7.9 Vétoquinol

7.9.1 Vétoquinol Business Overview

7.9.2 Vétoquinol Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.9.3 Vétoquinol Animal Pharmaceutical Product Introduction

7.9.4 Vétoquinol Response to COVID-19 and Related Developments

7.10 Jurox

7.10.1 Jurox Business Overview

7.10.2 Jurox Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.10.3 Jurox Animal Pharmaceutical Product Introduction

7.10.4 Jurox Response to COVID-19 and Related Developments

7.11 MSD Animal Health Australia

7.11.1 MSD Animal Health Australia Business Overview

7.11.2 MSD Animal Health Australia Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.11.3 MSD Animal Health Australia Animal Pharmaceutical Product Introduction

7.11.4 MSD Animal Health Australia Response to COVID-19 and Related Developments

7.12 PARNELL

7.12.1 PARNELL Business Overview

7.12.2 PARNELL Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.12.3 PARNELL Animal Pharmaceutical Product Introduction

7.12.4 PARNELL Response to COVID-19 and Related Developments

7.13 CAHIC

7.13.1 CAHIC Business Overview

7.13.2 CAHIC Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.13.3 CAHIC Animal Pharmaceutical Product Introduction

7.13.4 CAHIC Response to COVID-19 and Related Developments

7.14 Ringpu Biology

7.14.1 Ringpu Biology Business Overview

7.14.2 Ringpu Biology Animal Pharmaceutical Quarterly Production and Revenue, 2020

7.14.3 Ringpu Biology Animal Pharmaceutical Product Introduction

7.14.4 Ringpu Biology Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Animal Pharmaceutical Supply Chain Analysis

8.1.1 Animal Pharmaceutical Supply Chain Analysis

8.1.2 Covid-19 Impact on Animal Pharmaceutical Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Animal Pharmaceutical Distribution Channels

8.2.2 Covid-19 Impact on Animal Pharmaceutical Distribution Channels

8.2.3 Animal Pharmaceutical Distributors

8.3 Animal Pharmaceutical Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Animal Pharmaceutical Assessment

Table 9. COVID-19 Impact: Animal Pharmaceutical Market Trends

Table 10. COVID-19 Impact Global Animal Pharmaceutical Market Size

Table 11. Global Animal Pharmaceutical Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)

Table 12. Global Animal Pharmaceutical Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)

Table 13. Global Animal Pharmaceutical Quarterly Market Size, 2020 (US$ Million) & (K MT)

Table 14. Global Animal Pharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Animal Pharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)

Table 16. Global Animal Pharmaceutical Market Growth Drivers

Table 17. Global Animal Pharmaceutical Market Restraints

Table 18. Global Animal Pharmaceutical Market Opportunities

Table 19. Global Animal Pharmaceutical Market Challenges

Table 20. Key Manufacturers Animal Pharmaceutical Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Animal Pharmaceutical Market Size, 2019 (K MT) & (US$ Million)

Table 22. Animal Pharmaceutical Factory Price by Manufacturers 2020 (USD/MT)

Table 23. Location of Key Manufacturers Animal Pharmaceutical Manufacturing Plants

Table 24. Key Manufacturers Animal Pharmaceutical Market Served

Table 25. Date of Key Manufacturers Enter into Animal Pharmaceutical Market

Table 26. Key Manufacturers Animal Pharmaceutical Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Animal Pharmaceutical Market Size by Type, 2020, (US$ Million)

Table 29. Global Animal Pharmaceutical Market Size by Type, 2020 (K MT)

Table 30. Global Animal Pharmaceutical Price: by Type, 2020-2021 (USD/MT)

Table 31. Global Animal Pharmaceutical Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Animal Pharmaceutical Market Size by Application, 2020-2021 (K MT)

Table 33. Global Animal Pharmaceutical Price: by Application, 2020-2021 (USD/MT)

Table 34. Global Animal Pharmaceutical Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Animal Pharmaceutical Market Size by Region, 2019-2021 (K MT)

Table 36. By Country, North America Animal Pharmaceutical Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Animal Pharmaceutical Market Size, 2019-2021 (K MT)

Table 38. US Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 39. Canada Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Animal Pharmaceutical Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Animal Pharmaceutical Market Size, 2019-2021 (K MT)

Table 43. Germany Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 44. France Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 45. UK Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 46. Italy Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Animal Pharmaceutical Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Animal Pharmaceutical Market Size, 2019-2021 (K MT)

Table 50. China Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 51. Japan Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 52. South Korea Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 53. India Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 54. ASEAN Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 55. Latin America Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 56. Middle East and Africa Animal Pharmaceutical Market Size, 2019-2021 (US$ Million) & (K MT)

Table 57. Zoetis Business Overview

Table 58. Zoetis Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Zoetis Animal Pharmaceutical Product

Table 60. Zoetis Response to COVID-19 and Related Developments

Table 61. Merck Business Overview

Table 62. Merck Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Merck Animal Pharmaceutical Product

Table 64. Merck Response to COVID-19 and Related Developments

Table 65. Merial Business Overview

Table 66. Merial Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Merial Animal Pharmaceutical Product

Table 68. Merial Response to COVID-19 and Related Developments

Table 69. Elanco Business Overview

Table 70. Elanco Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Elanco Animal Pharmaceutical Product

Table 72. Elanco Response to COVID-19 and Related Developments

Table 73. Bayer Animal Health Business Overview

Table 74. Bayer Animal Health Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Bayer Animal Health Animal Pharmaceutical Product

Table 76. Bayer Animal Health Response to COVID-19 and Related Developments

Table 77. Boehringer Ingelheim Vetmedica Business Overview

Table 78. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product

Table 80. Boehringer Ingelheim Vetmedica Response to COVID-19 and Related Developments

Table 81. Virbac Business Overview

Table 82. Virbac Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Virbac Animal Pharmaceutical Product

Table 84. Virbac Response to COVID-19 and Related Developments

Table 85. Ceva Sante Animale Business Overview

Table 86. Ceva Sante Animale Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Ceva Sante Animale Animal Pharmaceutical Product

Table 88. Ceva Sante Animale Response to COVID-19 and Related Developments

Table 89. Vétoquinol Business Overview

Table 90. Vétoquinol Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Vétoquinol Animal Pharmaceutical Product

Table 92. Vétoquinol Response to COVID-19 and Related Developments

Table 93. Jurox Business Overview

Table 94. Jurox Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Jurox Animal Pharmaceutical Product

Table 96. Jurox Response to COVID-19 and Related Developments

Table 97. MSD Animal Health Australia Business Overview

Table 98. MSD Animal Health Australia Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. MSD Animal Health Australia Animal Pharmaceutical Product

Table 100. MSD Animal Health Australia Response to COVID-19 and Related Developments

Table 101. PARNELL Business Overview

Table 102. PARNELL Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. PARNELL Animal Pharmaceutical Product

Table 104. PARNELL Response to COVID-19 and Related Developments

Table 105. CAHIC Business Overview

Table 106. CAHIC Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. CAHIC Animal Pharmaceutical Product

Table 108. CAHIC Response to COVID-19 and Related Developments

Table 109. Ringpu Biology Business Overview

Table 110. Ringpu Biology Animal Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. Ringpu Biology Animal Pharmaceutical Product

Table 112. Ringpu Biology Response to COVID-19 and Related Developments

Table 113. Animal Pharmaceutical Distributors List

Table 114. Animal Pharmaceutical Customers List

Table 115. Covid-19 Impact on Animal Pharmaceutical Customers

List of Figures

Figure 1. Animal Pharmaceutical Product Picture

Figure 2. Animal Pharmaceutical Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Animal Pharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Animal Pharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Animal Pharmaceutical Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Animal Pharmaceutical Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Animal Pharmaceutical Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Animal Pharmaceutical Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Animal Pharmaceutical Market Size Market Share, 2019-2021